Free-cash-flow proxy decreased 29.9%
Free-cash-flow proxy changed -29.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$30.5M→$21.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ALKT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 28.9%
Operating cash flow changed -28.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$30.8M→$21.9M2 prior comparisons
Operating margin moved 677 bp higher
Operating margin changed +677 basis points from the comparable as-filed period.
-11.40%→-4.63%2 prior comparisons
Operating income increased 51.5%
Operating income changed +51.5% from the comparable as-filed period.
-$12.9M→-$6.2M2 prior comparisons
Net income increased 54.4%
Net income changed +54.4% from the comparable as-filed period.
-$14.8M→-$6.7M2 prior comparisons
Trade receivables increased 21.4%
Trade receivables changed +21.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$50.7M→$61.5M4 prior comparisons
Revenue increased 19.4%
Revenue changed +19.4% from the comparable as-filed period.
$113.0M→$134.9M2 prior comparisons
SBC / revenue moved 410 bp lower
SBC / revenue changed -410 basis points from the comparable as-filed period.
18.35%→14.25%2 prior comparisons
Free-cash-flow margin moved 1116 bp lower
Free-cash-flow margin changed -1116 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.03%→15.87%2 prior comparisons
Operating cash-flow margin moved 1103 bp lower
Operating cash-flow margin changed -1103 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.27%→16.24%2 prior comparisons
Capital expenditure increased 83.9%
Capital expenditure changed +83.9% from the comparable as-filed period.
$274,000→$504,0002 prior comparisons
Gross profit increased 20.9%
Gross profit changed +20.9% from the comparable as-filed period.
$64.1M→$77.6M2 prior comparisons
Cost of revenue increased 17.5%
Cost of revenue changed +17.5% from the comparable as-filed period.
$48.8M→$57.3M2 prior comparisons
Cash & equivalents decreased 12.2%
Cash & equivalents changed -12.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$57.3M→$50.3M4 prior comparisons
R&D / revenue moved 248 bp lower
R&D / revenue changed -248 basis points from the comparable as-filed period.
26.64%→24.16%2 prior comparisons
Gross margin moved 72 bp higher
Gross margin changed +72 basis points from the comparable as-filed period.
56.79%→57.50%2 prior comparisons
Current liabilities increased 13.2%
Current liabilities changed +13.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$80.6M→$91.2M4 prior comparisons
Research & development increased 8.3%
Research & development changed +8.3% from the comparable as-filed period.
$30.1M→$32.6M2 prior comparisons
Capex / revenue moved 13 bp higher
Capex / revenue changed +13 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.24%→0.37%2 prior comparisons
Stock-based compensation decreased 7.2%
Stock-based compensation changed -7.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$20.7M→$19.2M2 prior comparisons
Shares outstanding increased 1.9%
Shares outstanding changed +1.9% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
105,004,011→107,042,3198 prior comparisons
Stockholders' equity increased 2.7%
Stockholders' equity changed +2.7% from the comparable as-filed period.
$350.1M→$359.6M2 prior comparisons
Current assets increased 6.2%
Current assets changed +6.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$174.9M→$185.8M4 prior comparisons
Current ratio decreased 6.1%
Current ratio changed -6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
2.17→2.044 prior comparisons
Receivables / revenue moved 73 bp higher
Receivables / revenue changed +73 basis points from the comparable as-filed period.
44.86%→45.59%2 prior comparisons
Working capital / assets moved 4 bp higher
Working capital / assets changed +4 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
11.28%→11.32%4 prior comparisons
Working capital increased 0.3%
Working capital changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$94.2M→$94.5M4 prior comparisons
Total assets increased 0.0%
Total assets changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$835.2M→$835.2M4 prior comparisons
Operating margin moved 822 bp higher
Operating margin changed +822 basis points from the comparable as-filed period.
-14.16%→-5.93%2 prior comparisons
Operating income increased 51.4%
Operating income changed +51.4% from the comparable as-filed period.
-$15.9M→-$7.7M2 prior comparisons
Net income increased 34.5%
Net income changed +34.5% from the comparable as-filed period.
-$13.6M→-$8.9M2 prior comparisons
SBC / revenue moved 394 bp lower
SBC / revenue changed -394 basis points from the comparable as-filed period.
17.41%→13.47%2 prior comparisons
Revenue increased 15.9%
Revenue changed +15.9% from the comparable as-filed period.
$112.1M→$129.8M2 prior comparisons
Current liabilities increased 25.3%
Current liabilities changed +25.3% from the comparable as-filed period.
$66.4M→$83.2M3 prior comparisons
Gross margin moved 171 bp lower
Gross margin changed -171 basis points from the comparable as-filed period.
58.56%→56.85%2 prior comparisons
Cost of revenue increased 20.6%
Cost of revenue changed +20.6% from the comparable as-filed period.
$46.4M→$56.0M2 prior comparisons
R&D / revenue moved 280 bp lower
R&D / revenue changed -280 basis points from the comparable as-filed period.
26.98%→24.18%2 prior comparisons
Trade receivables increased 19.0%
Trade receivables changed +19.0% from the comparable as-filed period.
$47.7M→$56.7M3 prior comparisons
Working capital decreased 15.4%
Working capital changed -15.4% from the comparable as-filed period.
$111.4M→$94.3M3 prior comparisons
Cash & equivalents decreased 13.2%
Cash & equivalents changed -13.2% from the comparable as-filed period.
$52.4M→$45.5M3 prior comparisons
Gross profit increased 12.5%
Gross profit changed +12.5% from the comparable as-filed period.
$65.6M→$73.8M2 prior comparisons
Stockholders' equity increased 5.4%
Stockholders' equity changed +5.4% from the comparable as-filed period.
$344.0M→$362.7M2 prior comparisons
Stock-based compensation decreased 10.4%
Stock-based compensation changed -10.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$19.5M→$17.5M2 prior comparisons
Current ratio decreased 20.3%
Current ratio changed -20.3% from the comparable as-filed period.
2.68→2.133 prior comparisons
Working capital / assets moved 192 bp lower
Working capital / assets changed -192 basis points from the comparable as-filed period.
13.26%→11.34%3 prior comparisons
Total assets decreased 1.1%
Total assets changed -1.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$840.4M→$831.1M3 prior comparisons
Shares outstanding increased 2.7%
Shares outstanding changed +2.7% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
104,083,138→106,941,9808 prior comparisons
Research & development increased 3.9%
Research & development changed +3.9% from the comparable as-filed period.
$30.2M→$31.4M2 prior comparisons
Receivables / revenue moved 113 bp higher
Receivables / revenue changed +113 basis points from the comparable as-filed period.
42.55%→43.68%2 prior comparisons
Current assets decreased 0.2%
Current assets changed -0.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$177.8M→$177.5M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.